Evidence map›Paper›PMID 29415989›Full record

ArticleCell death & disease2018

Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function.

Zhiqiang Li, Inamul Kabir, Gladys Tietelman, Chongmin Huan, Jianglin Fan, Tilla Worgall, Xian-Cheng Jiang

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Effect of Total SMS Activity on LDL Catabolism in Mice.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  15. ORMDL in metabolic health and disease.Pharmacology & therapeutics · 2023
    Review
  16. Article
  17. Contribution of specific ceramides to obesity-associated metabolic diseases.Cellular and molecular life sciences : CMLS · 2022
    Review
  18. Article
  19. Article
  20. Ceramide signaling in the gut.Molecular and cellular endocrinology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Zhiqiang LiDepartment of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203, USA.
Inamul KabirDepartment of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203, USA.
Gladys TietelmanDepartment of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203, USA.
Chongmin HuanDepartment of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203, USA.
Jianglin FanDepartment of Molecular Pathology, University of Yamanashi, Yamanashi, Japan.
Tilla WorgallDepartment of Medicine, Columbia University, New York, NY, 10032, USA.
Xian-Cheng JiangDepartment of Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203, USA. XJiang@downstate.edu.
State University of New York · USSUNY Downstate Health Sciences University · USColumbia University · USUniversity of Yamanashi · JPVA NY Harbor Healthcare System · US

Funding

Effect of sphingomyelin biosynthesis on atherosclerosisR01HL149730 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG · 2020 to 2023
$1.9M
THE ROLE OF PLASMA SPHINGOMYELIN IN ATHEROSCLEROSISR01HL064735 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG · 2001 to 2004
$1.1M
Hepatic PLTP as a target for lowering LDL-cR56HL121409 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG, JIN, WEIJUN · 2014 to 2014
$400k
NHLBI NIH HHS R01 HL064735NHLBI NIH HHS R01 HL149730NHLBI NIH HHS R56 HL121409
6 · The paper itself

Abstract

Serine palmitoyltransferase (SPT) is the rate-limiting enzyme for sphingolipid biosynthesis. SPT has two major subunits, SPTLC1 and SPTLC2. We previously found that liver Sptlc2 deficiency in early life impairs the development of adherens junctions. Here, we investigated the role of Sptlc2 deficiency in intestine. We treated Sptlc2-Flox/villin-Cre-ER

Indexed as

AnimalsCadherinsCell DifferentiationCell MembraneCell ProliferationCell SurvivalColonInflammatory Bowel DiseasesIntestinesIntestine, SmallMice, KnockoutMitogen-Activated Protein KinasesMucin-2Organ SpecificitySerine C-PalmitoyltransferaseSphingolipidsCadherinsMitogen-Activated Protein KinasesMucin-2Serine C-PalmitoyltransferaseSphingolipidsSptlc2 protein, mouse

Identifiers

PMID29415989
PMCPMC5833386
OpenAlexW2792613176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.